The Scientific World Journal / 2012 / Article / Tab 6

Research Article

Polyvascular Disease in Patients Presenting with Acute Coronary Syndrome: Its Predictors and Outcomes

Table 6

Risk factors and in-hospital mortality in patients with versus without polyvascular disease presenting with acute coronary syndrome in different clinical studies.

GRACE (n = 32735) [7]MASCARA (n = 6745) [9]GULFRACE-2 ( đť‘› = 7 6 8 9 ) ALLIANCE (n = 8904) [6]
APolyVD (15.6%)APolyVD (16.6%)APolyVD (5.6%)APolyVD (13%)
BCDBCDBCDBCD

Patients %847628396294140.687841
Age (mean yrs)6471737367707372566365666572
Smoking5969536836/28*61/22*44/16*60/21*545439625963
Diabetes mellitus2238344228494352387761821934
Hypertension5872788258727669457279824866
Dyslipidemia4658526546575053365553674347
Renal failureN/AN/AN/AN/AN/AN/AN/AN/A3201030312

Mortality4.57.28.99.24.89.19.2164127155.79.81413

A: acute coronary syndrome (ACS) alone; B: ACS plus peripheral arterial disease (PAD); C: ACS plus cerebrovascular disease (CVD); D: ACS plus PAD plus CVD; PolyVD: polyvascular disease, all categorical variables represents in percentage (%); DM: diabetes mellitus; N/A: data not available; *prior/current smoking. Data were collected from [6, 7, 9].

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.